Changes in Ownership

Keros Therapeutics, Inc. Filed 2025-10-15 Acc 0000902664-25-004411

Documents 1

2025-10-17 4 Changes in Ownership
2025-10-16 SCHEDULE 13D/A Beneficial Ownership Report
2025-10-15 SC TO-C Written Communication Relating to an Issuer
2025-10-15 8-K Material agreement · Results of operations · Executive or director change · Regulation FD disclosure · Other events
2025-10-15 4 Changes in Ownership
2025-10-15 SCHEDULE 13D/A Beneficial Ownership Report
2025-09-05 4 Changes in Ownership

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xslF345X05/ownership.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…